» Articles » PMID: 35955963

Forest Biomass As a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 12
PMID 35955963
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder affecting elderly people worldwide. Currently, there are no effective treatments for AD able to prevent disease progression, highlighting the urgency of finding new therapeutic strategies to stop or delay this pathology. Several plants exhibit potential as source of safe and multi-target new therapeutic molecules for AD treatment. Meanwhile, extracts revealed important pharmacological activities, namely antioxidant and anti-inflammatory properties, which can contribute to the reported neuroprotective effects. This review summarizes the chemical composition of essential oil (EO) and phenolic extracts obtained from leaves, disclosing major compounds and their effects on AD-relevant pathological features, including deposition of amyloid-β (Aβ) in senile plaques and hyperphosphorylated tau in neurofibrillary tangles (NFTs), abnormalities in GABAergic, cholinergic and glutamatergic neurotransmission, inflammation, and oxidative stress. In general, 1,8-cineole is the major compound identified in EO, and ellagic acid, quercetin, and rutin were described as main compounds in phenolic extracts from leaves. EO and phenolic extracts, and especially their major compounds, were found to prevent several pathological cellular processes and to improve cognitive function in AD animal models. Therefore, leaves are a relevant source of biological active and safe molecules that could be used as raw material for nutraceuticals and plant-based medicinal products useful for AD prevention and treatment.

Citing Articles

Exploring the mechanism of agarwood moxa smoke in treating sleep disorders based on GC-MS and network pharmacology.

Chen N, Xia Y, Wu W, Chen S, Zhao M, Song Y Front Med (Lausanne). 2024; 11:1400334.

PMID: 38784223 PMC: 11114445. DOI: 10.3389/fmed.2024.1400334.

References
1.
Kaufmann D, Kaur Dogra A, Wink M . Myrtenal inhibits acetylcholinesterase, a known Alzheimer target. J Pharm Pharmacol. 2011; 63(10):1368-71. DOI: 10.1111/j.2042-7158.2011.01344.x. View

2.
Kim H, Park B, Lee K, Choi C, Jang S, Kim Y . Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem. 2005; 53(22):8537-41. DOI: 10.1021/jf051985c. View

3.
Ben Slimane B, Ezzine O, Dhahri S, Ben Jamaa M . Essential oils from two Eucalyptus from Tunisia and their insecticidal action on Orgyia trigotephras (Lepidotera, Lymantriidae). Biol Res. 2014; 47:29. PMC: 4112207. DOI: 10.1186/0717-6287-47-29. View

4.
Elaissi A, Medini H, Khouja M, Simmonds M, Lynen F, Farhat F . Variation in volatile leaf oils of five Eucalyptus species harvested from Jbel Abderrahman arboreta (Tunisia). Chem Biodivers. 2011; 8(2):352-61. DOI: 10.1002/cbdv.201000102. View

5.
Dezsi S, Badarau A, Bischin C, Vodnar D, Silaghi-Dumitrescu R, Gheldiu A . Antimicrobial and antioxidant activities and phenolic profile of Eucalyptus globulus Labill. and Corymbia ficifolia (F. Muell.) K.D. Hill & L.A.S. Johnson leaves. Molecules. 2015; 20(3):4720-34. PMC: 6272638. DOI: 10.3390/molecules20034720. View